Day One - EST/EDT (Eastern Daylight, GMT-4)
Day One - EST/EDT (Eastern Daylight, GMT-4)
- Mitesh Ghia - Director, Institutional Contracts, Chargebacks & Rebates, Novartis Pharmaceuticals Corporations
The commercial contracts space is ever evolving. Success in this industry requires manufacturers, wholesalers, trading partners, etc., to keep up with policy changes, regulations, and increasing competition. Join us in this session as we delve into the hot topics surrounding:
- Updates on current policies and reforms
- Examining current and future pricing initiatives
- Managing WAC changes
- And more!
- Rosalind Davis - Director, Government Pricing and Contracts, CSL Vifor
- Stephanie Kupski - Director US Pricing & Government Reporting, CSL Behring
Explore the new Inflation Reduction Act (IRA) and the anticipated impact it will have on the contracts and chargebacks industry. How will the new IRA be implemented? What will negotiations look like moving forward? How will it influence current drug pricing and contracting? Take a deep-dive into:
Impacts on process amendments
Financial impact on GTN
Modeling the impact for specific franchises
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
- Bob Steller - Industry Principal for Life Sciences, Vistex
As the 340B Program has grown exponentially over the last few years and due to lack of transparency and collaboration across the pharmaceutical supply chain (i.e wholesalers, Medicaid State Agencies, PBM(s), healthcare providers), it has become of utmost importance that Pharmaceutical Manufacturers adopt a data analytics enabled approach and have ongoing monitoring mechanisms in place to monitor 340B utilization at Covered Entities. This will help pharmaceutical manufacturers gain AI- enabled insights and facilitate data driven decision making to increase oversight over third parties and reduce revenue leakage.
- Mitesh Ghia - Director, Institutional Contracts, Chargebacks & Rebates, Novartis Pharmaceuticals Corporations
- Thomas Bogle - Director, PwC
- Aakash Shah - Senior Manager, PwC
- Sandhya Aribandi - Senior Manager, Exponential AI
- Partnering with distributors and wholesalers to ensure overall customer success
- Overcoming terminology challenges
- GPO perspective — roster management, membership, and administration.
- MediLedger perspective – Updates on removing manual process
- Beth Stevens - Director, Contracts & Pricing, TOLMAR Pharmaceuticals
- Sean Lawrence - Associate Director, Chargebacks & Memberships, Teva Pharmaceutical
- Cheryl Shuck - Associate Director, Chargebacks & Memberships, Teva Pharmaceuticals
Discuss the complexities in managing GPO, 340b and individual hospital system contracts. Discover ways to specifically streamline the management process and avoid mishandling contracts.
- Jennifer Crosswell - Director, Contracts & Pricing, Accounting, Azurity Pharmaceuticals
- Venus Taylor - Manager, Contracts Operations & Rebates, Azurity Pharmaceuticals
Join us for this session to discuss the in-and-outs of contract analysis and trends with topics such as:
How sufficient data is being pulled and segmented
Applying robust data analytics and machine learning to pharma claims
Identifying and preventing revenue leakage through data control
And more
- Leonard Rampersaud - Senior Manager, Contracting & Commercial Operations, Jazz Pharmaceuticals
- Roxana Santiago - Director Revenue Accounting, Medline
- 20-minute blocks
- Wholesalers and manufacturers
- Who do you contact with questions for errors? Who do you contact when you need details on the process for filing this and that? Sign-up your team to meet your contacts at some of the top Wholesalers nationwide. These meet-and-greets are for connecting and learning the processes and needs for each stakeholder to work collaboratively together.
- Chad Snyder - Director, Global Finance Shared Services, Cardinal Health
Join this facilitated and interactive discussion with peers across industry to hear how their internal teams are set up and share strategies around efficiency and innovations, including the structure of resources for near term implementation of the IRA and long-term strategy, hiring to manage 340B and more. Topics will include:
- Current case studies on department set up/reviewing organizational structure
- Outsourcing pros and cons
- Challenges faced with current set up
- How is your company planning to structure resources and plan for the addition of the IRA responsibilities? Will this fall under Gov’t Rebates or Commercial Rebates? (panel)
- Strategies to identify and cultivate qualified and diverse talent for roles in this space (including analysts etc.)
- Erika Chiles-George - Head of Pricing, Contracting and Trade, Neurocrine Biosciences
- Susan Dunne - Senior Director, Riparian
- Lynn Buhl - Senior Director, Riparian